Engineering and early career
Osdoit is a biomedical engineer with degrees from Ecole Polytechnique in Paris and Johns Hopkins University in Baltimore, Maryland, plus further degrees in biostatistics and corporate finance.1
Before Sofinnova she held several key positions at Mauna Kea Technologies, a Paris medical technology company, and worked on financing rounds including its 2011 initial public offering.1
Sofinnova and Moon Surgical
Osdoit joined Sofinnova Partners as a partner in 2015 and runs its MD Start accelerator. She was also founding CEO of SafeHeal and May Health and sits on both boards.1
She joined Moon Surgical as CEO when it was founded in 2020. Under her, Maestro won commercial FDA clearance in June 2024, and the company signed a commercial collaboration with KARL STORZ in July 2026.2,3,4
Scalable Surgery depends on the operating room ecosystem working together, not on any one, single device.PR Newswire, July 22, 2026
Links
Sources
- Sofinnova Partners, Anne Osdoit, accessed November 3, 2026
- Moon Surgical, Company, accessed November 3, 2026
- Sofinnova Partners, Moon Surgical receives second FDA clearance, covering its commercial Maestro surgical robotics system, June 4, 2024, accessed November 3, 2026
- PR Newswire, Moon Surgical and KARL STORZ announce strategic commercial collaboration, July 22, 2026, accessed November 3, 2026
Photo: Moon Surgical, Company.
